Latest Breaking News On - Acasti pharma - Page 14 : comparemela.com

Acasti Pharma (ACST) Announces Resignation of Jean-Marie Canan from Board

Acasti Pharma (ACST) Announces Resignation of Jean-Marie Canan from Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jean marie john cananJean marie cananAcasti pharmaAcasti pharma incBoard of directors the companyAnnounces resignationCategories board changes

Acasti Pharma Inc Centralizes Marketplace for Shares on the Nasdaq with Voluntary Delisting from TSX Venture Exchange

Acasti also confirms no exposure to Silicon Valley Bank or Silvergate Bank LAVAL, Québec, March 13, 2023 /PRNewswire/ Acasti Pharma Inc. a late-stage, specialty pharma company. | March 13, 2023

United statesRobert blumJan dalviseSilicon valley bankSilvergate bankAcasti pharma incLytham partnersSecurities exchangeRegulation services providerVenture exchangeAcasti pharmaOrphan drug designationSubarachnoid hemorrhagePostherpetic neuralgiaSecurities litigation reform actSecurities act

Acasti Pharma Recognizes Rare Disease Day

Acasti Pharma Recognizes Rare Disease Day
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLlcrobert blumtelAcasti pharmaJan dalviseAcasti pharma incPrnewswire acasti pharma incSecurities exchangeEuropean organization for rare diseasesRegulation services providerRare disease dayEuropean organizationJand alviseOrphan drug designationSubarachnoid hemorrhagePostherpetic neuralgiaLooking statementsstatements

Acasti Pharma Recognizes Rare Disease Day

/PRNewswire/ Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical.

United statesRobert blumAcasti pharmaJan dalviseAcasti pharma incPrnewswire acasti pharma incLytham partnersSecurities exchangeEuropean organization for rare diseasesRegulation services providerRare disease dayEuropean organizationJand alviseOrphan drug designationSubarachnoid hemorrhagePostherpetic neuralgia

Acasti Pharma Inc (NASDAQ:ACST) Q3 2023 Earnings Call Transcript

Company Representatives: Jan D Alvise - President, Chief Executive Officer Brian Ford - Chief Financial Officer Pierre Lemieux - Chief Operating and Scientific Officer, Co-Founder Prashant Kohli - Chief.

United statesOren livnatPierre lemieuxLeland gershellPrashant kohliRobert blumBrian fordJan dalviseAcasti pharmaExchange commissionAcasti pharma incAcasti coCompany representativesCall transcript februaryJand alviseChief executive officer brian ford